C07K 14/235
From bordetella
Official title: from Bordetella (G)
C07K14/235 (From bordetella) appears on 211 US grants and 150 published applications in this corpus.
Search patents in C07K- Granted patents
- 211
- Published applications
- 150
- Assignees
- 131
- Inventors
- 424
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 6 | 0 |
| 1990 | 0 | 0 |
| 1991 | 7 | 0 |
| 1992 | 7 | 0 |
| 1993 | 7 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 14 | 0 |
| 1999 | 17 | 0 |
| 2000 | 10 | 0 |
| 2001 | 8 | 3 |
| 2002 | 6 | 8 |
| 2003 | 2 | 10 |
| 2004 | 4 | 4 |
| 2005 | 3 | 7 |
| 2006 | 8 | 11 |
| 2007 | 3 | 3 |
| 2008 | 4 | 5 |
| 2009 | 2 | 5 |
| 2010 | 4 | 6 |
| 2011 | 3 | 4 |
| 2012 | 5 | 3 |
| 2013 | 4 | 8 |
| 2014 | 7 | 8 |
| 2015 | 8 | 14 |
| 2016 | 8 | 6 |
| 2017 | 3 | 5 |
| 2018 | 4 | 3 |
| 2019 | 2 | 3 |
| 2020 | 6 | 5 |
| 2021 | 3 | 6 |
| 2022 | 3 | 4 |
| 2023 | 1 | 4 |
| 2024 | 4 | 5 |
| 2025 | 2 | 6 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fermentation process24 Feb 2026US 12,559,713 B2Glaxosmithkline Biologicals SA
- Methods and compositions related to the next generation vaccine17 Jun 2025US 12,331,085 B2University of Kansas
- Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins25 Feb 2025US 12,233,119 B2Prime Bio, Inc.
- Production of soluble recombinant proteins without N-terminal methionine in E-coli1 Oct 2024US 12,104,161 B2Fina BioSolutions, LLC
- Methods of cultivating Bordetella species30 Apr 2024US 11,970,690 B2Sanofi Pasteur Limited
- A broadly protective prophylactic vaccine against pseudomonas aeruginosa24 Sep 2026US 2026/0284172 A1University of Kansas
- Optimized epicutaneous vaccination23 Apr 2026US 2026/0108593 A1Bionet-Asia, Co. Ltd.
- Diphtheria-tetanus-pertussis compound adjuvant combined vaccine16 Apr 2026US 2026/0102480 A1Changchun BCHT Biotechnology Co.
- Vaccines targeting c. acnes hyaluronidase for prophylaxis and treatment of acne vulgaris29 Jan 2026US 2026/0027194 A1Cedars-Sinai Medical Center
- Bordetella T Cells Epitopes, Megapools and Uses Thereof6 Nov 2025US 2025/0341513 A1
Most cited
By later US patents
- Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines76US 5,759,551 AUnited Biomedical, Inc. · 1998
- Procaryotic leader sequence in recombinant baculovirus expression system61US 5,322,774 ABurroughs Wellcome Co. · 1994
- Vaccine57US 5,786,189 ASmithKline Beecham Biologicals s.a. · 1998
- Genetic detoxification of pertussis toxin54US 5,085,862 AConnaught Laboratories Limited · 1992
- Adhesin antigens, antibodies and DNA fragment encoding the antigen, methods and means for diagnosis and immunization etc.44US 4,795,803 ASyn-Tek AB · 1989